Page last updated: 2024-12-05

bucrylate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Bucrylate: Cyanoacrylate tissue adhesive also used to occlude blood vessels supplying neoplastic or other diseased tissue. [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID14046
CHEMBL ID2103950
SCHEMBL ID168360
MeSH IDM0002996

Synonyms (36)

Synonym
2hjv1f859z ,
bucrilato
unii-2hjv1f859z
bucrilatum
bucrilate [inn]
2-propenoic acid,2-cyano-, 2-methylpropyl ester
1069-55-2
bucrilate (inn)
D03172
bucrylate (usan)
isobutyl 2-cyanacrylat
bucrylate [usan]
bucrilatum [inn-latin]
bucrylate
bucrilato [inn-spanish]
ccris 1694
bucrilate
isobutyl 2-cyanoacrylate
einecs 213-958-1
2-propenoic acid, 2-cyano-, 2-methylpropyl ester
IBC ,
2-methylpropyl 2-cyanoprop-2-enoate
AKOS006275709
26809-38-1
isobutyl cyanoacrylate
isobutyl cyanoacrylate [mi]
bucrilate [who-dd]
bucrilate [mart.]
CHEMBL2103950
SCHEMBL168360
QRWOVIRDHQJFDB-UHFFFAOYSA-N
DTXSID1061447
Q10859787
BAA06955
EN300-1440051
isobutyl2-cyanoacrylate

Research Excerpts

Overview

Bourrylate embolization is a potentially useful adjunct to nonresective treatment of abdominal aortic aneurysms. Bucrylate proved to be an effective oral hemostat, rapidly retarding postextraction hemorrhage.

ExcerptReferenceRelevance
"Bucrylate embolization is a potentially useful adjunct to nonresective treatment of abdominal aortic aneurysms."( Bucrylate embolization of abdominal aortic aneurysms: an adjunct to nonresective therapy.
Goldman, ML; Karmody, AM; Leather, RP; Parikh, N; Philip, PK; Powers, SR; Sarrafizadeh, MS, 1980
)
2.43
"Bucrylate seems to be a suitable embolus inducing agent."( Transcatheter embolization of the renal artery with bucrylate in renal carcinoma.
Klevmark, B; Skjennald, A; Stenwig, JT, 1980
)
1.23
"Bucrylate was found to be a valuable agent when used to: (1) occlude vessels with very slow flow; (2) occlude vessels in patients with coagulopathies; (3) occlude high flow arteriovenous fistulas; (4) perform superselective vessel occlusion; and (5) produce permanent vessel obliteration."( Transcatheter occlusive therapy of genitourinary abnormalities using isobutyl 2-cyanoacrylate (Bucrylate).
Bush, WH; Freeny, PC; Kidd, R, 1979
)
1.2
"Bucrylate proved to be an effective oral hemostat, rapidly retarding postextraction hemorrhage."( Studies concerning the hsitotoxicity of isobutyl-2-cyanoacrylate tissue adhesive when employed as an oral hemostat.
Greer, RO, 1975
)
0.98

Compound-Compound Interactions

ExcerptReferenceRelevance
" The purpose of this study was to compare 2 techniques, 1) guided tissue regeneration (GTR) with a bioabsorbable polylactic acid softened with citric acid ester membrane and 2) the connective tissue graft combined with a coronally positioned pedicle graft without vertical incisions."( A comparison of 2 root coverage techniques: guided tissue regeneration with a bioabsorbable matrix style membrane versus a connective tissue graft combined with a coronally positioned pedicle graft without vertical incisions. results of a series of consec
Harris, RJ, 1998
)
0.3

Bioavailability

ExcerptReferenceRelevance
"This paper describes two new possibilities of using cyclodextrins to increase water solubility and bioavailability of poorly water-soluble drugs intended for targeting delivery by the oral or the parenteral route."( Cyclodextrins and carrier systems.
Duchêne, D; Ponchel, G; Wouessidjewe, D, 1999
)
0.3

Dosage Studied

ExcerptRelevanceReference
" The agents produced an efficient and lasting embolization, with no evident complication; however, their usage is difficult and an appropriate dosage is also difficult."( Cyanoacrylates in transcatheter renal embolization.
Belgrano, E; Carmignani, G; Giuliani, L; Puppo, P, 1978
)
0.26
" Optimizing the dosage of CA, choice of animal model, inverted anastomosis construction, and other method details may improve intestinal and colorectal anastomoses with CA application in future studies."( Critical analysis of cyanoacrylate in intestinal and colorectal anastomosis.
Boersema, GS; Daams, F; Jeekel, J; Kleinrensink, GJ; Lange, JF; Sparreboom, CL; Vakalopoulos, KA; Wu, Z, 2014
)
0.4
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (250)

TimeframeStudies, This Drug (%)All Drugs %
pre-1990172 (68.80)18.7374
1990's40 (16.00)18.2507
2000's29 (11.60)29.6817
2010's9 (3.60)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 13.57

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index13.57 (24.57)
Research Supply Index5.67 (2.92)
Research Growth Index4.06 (4.65)
Search Engine Demand Index10.37 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (13.57)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (0.35%)5.53%
Reviews12 (4.17%)6.00%
Case Studies89 (30.90%)4.05%
Observational0 (0.00%)0.25%
Other186 (64.58%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]